Hyperbilirubinemia Among African American, Glucose-6-Phosphate Dehydrogenase-Deficient Neonates
Authors:
- 1 August 2004
- journal article
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- Vol. 114 (2) , e213-e219
Abstract
Background. Although glucose-6-phosphate dehydrogenase (G-6-PD) deficiency is prevalent in African Americans, their risk of associated neonatal hyperbilirubinemia has not been prospectively studied. Objective. To compare hemolysis and the risk of hyperbilirubinemia among African American, G-6-PD-deficient neonates (study group) and G-6-PD-normal control subjects. Methods. Consecutive, healthy, term and near-term, male neonates born to African American mothers comprised the patient cohort. G-6-PD testing was performed with umbilical cord blood samples. Routine management included measurement of the end tidal carbon monoxide level corrected for ambient carbon monoxide level (ETCOc) within 4 hours after delivery (assessment of hemolysis), ≥1 predischarge bilirubin determination, and additional bilirubin testing as clinically indicated. Indications for phototherapy were identical for study patients and control subjects. Neonates were monitored for the first 1 week of life. ETCOc results, the incidence of hyperbilirubinemia (defined as a transcutaneous or plasma total bilirubin concentration of ≥95th percentile for the hour of life), and the need for phototherapy were compared between the G-6-PD-deficient and G-6-PD-normal groups. Results. Five hundred male patients were enrolled, of whom 64 (12.8%) were G-6-PD-deficient. ETCOc values (median and interquartile range) were higher among G-6-PD-deficient neonates than among control neonates (2.4 ppm [2.0–2.9 ppm] vs 2.1 ppm [1.7–2.5 ppm]). More G-6-PD-deficient neonates developed hyperbilirubinemia than did control subjects (14 of 64, 21.9%, vs 29 of 436, 6.7%; relative risk: 3.27; 95% confidence interval: 1.83-5.86), whereas 13 (20.3%) met the criteria for phototherapy, compared with 25 control subjects (5.7%) (relative risk: 3.53; 95% confidence interval: 1.91-6.56). No cases of kernicterus were observed. Conclusions. Within the African American neonatal population, there is a subgroup of G-6-PD-deficient infants with elevated rates of hemolysis, a higher incidence of hyperbilirubinemia, and a greater requirement for phototherapy, compared with G-6-PD-normal control subjects. These newborns should be monitored vigilantly for the development of hyperbilirubinemia.Keywords
This publication has 41 references indexed in Scilit:
- Corrected End-Tidal Carbon Monoxide Closely Correlates With the Corrected Reticulocyte Count in Coombs’ Test-Positive Term NeonatesPediatrics, 2003
- Conjugated bilirubin in neonates with glucose-6-phosphate dehydrogenase deficiencyThe Journal of Pediatrics, 1996
- Glucose-6-phosphate dehydrogenase deficiency and carboxyhemoglobin concentrations associated with bilirubin-related morbidity and death in Nigerian infantsThe Journal of Pediatrics, 1995
- Molecular characterization of glucose‐6‐phosphate dehydrogenase deficiency in Chinese infants with or without severe neonatal hyperbilirubinaemiaBritish Journal of Haematology, 1994
- Hyperbilirubinemia in Black InfantsClinical Pediatrics, 1992
- Glucose‐6‐Phosphate Dehydrogenase Deficiency and Neonatal Jaundice in JamaicaBritish Journal of Haematology, 1979
- Clinical Implications of Sickle-Cell Trait and Glucose-6-Phosphate Dehydrogenase Deficiency in Hospitalized Black Male PatientsNew England Journal of Medicine, 1979
- Kernicterus in a newborn female with G-6-PD deficiencyThe Journal of Pediatrics, 1976
- The relationship of erythrocyte glucose-6-phosphate dehydrogenase deficiency to hyperbilirubinemia in Negro premature infantsThe Journal of Pediatrics, 1967
- Serum bilirubin levels and glucose-6-phosphate dehydrogenase deficiency in newborn American NegroesThe Journal of Pediatrics, 1963